Zhifei Biological Products stated that it would adopt multiple measures to reduce market risks amid criticism over its stock price having 'fallen to nothing.' | Earnings Call Highlights

① Investors at the ZhiFei Bio earnings meeting generally focused on the measures the company plans to adopt to stabilize its financial condition; ② The company stated that due to fluctuating market demand and other factors, its short-term performance remains under pressure.

cls.cnMay 8 22:18

This company signs a major computing power service contract with a maximum value of 19 billion yuan | Post-market announcement highlights

Jinli Huadian: Plans to purchase equity in Zhongke Xiguang; trading suspension begins on May 6.

cls.cnMay 5 19:12

The dual drivers of the silver economy and the younger generation's focus on health have made the tonic category the main growth engine of the traditional Chinese medicine industry.

① According to the annual report data disclosed by listed companies in 2025, tonic medicines have become the most certain growth track in the traditional Chinese medicine industry; ② Judging from the new product layouts of various proprietary Chinese medicine enterprises, the level of emphasis placed on the tonic track by these companies has also significantly increased.

cls.cnMay 1 22:02

AI Computing Power 'Unprecedented Prosperity' Achieved! Trillion-Dollar Giant's Q1 Net Profit Doubles | Post-Market Announcement Highlights

A trillion-yuan 'contract manufacturing giant' doubles its net profit year-on-year in a single quarter; a 'star stock' in the domestic computing power chip sector announces an ambitious profit distribution plan; a leading company in the resources segment reports a nearly 30-fold surge in quarterly net profit...

Golden10 DataApr 28 20:55

Mindray Medical: Strong growth in international business drove over half of the revenue in Q1 2026, while domestic business faced pressure with declining profits but showed structural improvements.

Mindray Medical's Q1 2026 Earnings Report: International Business Demonstrates Strong Growth, Domestic Challenges Weigh on Profitability; Core Logic Remains Intact. Key Highlights of Financial Performance: 2...

wallstreetcnApr 28 19:00

Declines in both A-shares and H-shares: The ChiNext Index fell by over 1%, while the biotechnology sector surged, with Wuxi Apptec hitting the daily price limit. The Hang Seng Tech Index dropped nearly 1%, and technology stocks underwent adjustments.

In early trading, the CRO concept gained strength, with Wuxi Apptec approaching the upper limit. Kailaiying, Boteng Shares, Kanglong Huacheng, Yaoshi Technology, and Hongbo Medicine also rose. Semiconductor equipment stocks fell sharply, with ACM Research dropping more than 10%, and Topec Technologies nearing the lower limit. Core Micro, Silicon Electric Shares, Naikuo Equipment, and Jing Sheng Shares followed the downward trend.

wallstreetcnApr 28 10:16